ロード中...
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies
Several mechanisms facilitate the progression of hormone-sensitive prostate cancer to castration-resistant prostate cancer (CRPC). At present, the approved chemotherapies for CRPC include systemic drugs (docetaxel and cabazitaxel) and agents that target androgen signaling, including enzalutamide and...
保存先:
| 出版年: | Am J Clin Exp Urol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539108/ https://ncbi.nlm.nih.gov/pubmed/26309896 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|